Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level

被引:309
|
作者
Kmiecik, Justyna [1 ]
Poli, Aurelie [1 ]
Brons, Nicolaas H. C.
Waha, Andreas [2 ]
Eide, Geir Egil [3 ,4 ]
Enger, Per Oyvind [5 ]
Zimmer, Jacques
Chekenya, Martha [1 ,6 ]
机构
[1] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway
[2] Univ Hosp, Dept Neuropathol, Bonn, Germany
[3] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway
[4] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway
[5] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway
[6] Univ Bergen, Dept Clin Dent, N-5009 Bergen, Norway
关键词
GBM; Tumor infiltrating cells; Regulatory T cells; Antigen presenting cells; REGULATORY T-CELLS; MGMT PROMOTER METHYLATION; NATURAL-KILLER-CELLS; NK CELLS; ADJUVANT TEMOZOLOMIDE; PROGNOSTIC VALUE; RECEPTOR; CANCER; EXPRESSION; NKG2D;
D O I
10.1016/j.jneuroim.2013.08.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We characterized GBM patients' tumor and systemic immune contexture with aim to reveal the mechanisms of immunological escape, their impact on patient outcome, and identify targets for immunotherapy. Increased CD3 T-cell infiltration was associated with prolonged survival independent of age, MGMT promoter methylation and post-operative treatment that implies potential for immunotherapy for GBM. Several mechanisms of escape were identified: within the tumor microenvironment: induced cD8+cD28 Foxp3 Tre that may tolerize antigen presenting cells, elevated CD73 and CD39 ectonucleotidases that suppress T-cell function, and at the systemic level: elevated IL-10 levels in serum, diminished helper T-cell counts, and upregulated inhibitory CTLA-4. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:71 / 83
页数:13
相关论文
共 50 条
  • [31] A Pro-Inflammatory Tumor Microenvironment with High Chemokine Expression and High Tumor-Infiltrating CD3+CD8+Numbers Associates with Improved Survival in Ewing Sarcoma (EWS)
    Berghuis, D.
    Santos, S. J.
    Baelde, J. J.
    Taminiau, A. H. M.
    Egeler, R. M.
    Schilham, M. W.
    Hogendoorn, P. C. W.
    Lankester, A. C.
    MODERN PATHOLOGY, 2010, 23 : 15A - 15A
  • [32] Synergistic upregulation of PD-L1 in tumor cells and CD39 in tumor-infiltrating CD8+ T cells leads to poor prognosis in patients with hepatocellular carcinoma
    Kang, Xi
    Zhao, Sinan
    Lin, Shan
    Li, Jing
    Wang, Shunxiang
    ONCOLOGY LETTERS, 2024, 28 (02)
  • [33] Tumor-Infiltrating CD45RO+-Cell Density, but Not CD3+, CD8+, or FOXP3+-Cell Density, Has a Prognostic Role in Colorectal Cancer, Independent of Molecular Features
    Nosho, K.
    Dranoff, G.
    Fuchs, C.
    Ogino, S.
    LABORATORY INVESTIGATION, 2011, 91 : 160A - 160A
  • [34] Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer
    Egelston, Colt A.
    Guo, Weihua
    Tan, Jiayi
    Avalos, Christian
    Simons, Diana L.
    Lim, Min Hui
    Huang, Yinghui J.
    Nelson, Michael S.
    Chowdhury, Arnab
    Schmolze, Daniel B.
    Yim, John H.
    Kruper, Laura
    Melstrom, Laleh
    Margolin, Kim
    Mortimer, Joanne E.
    Yuan, Yuan
    Waisman, James R.
    Lee, Peter P.
    JCI INSIGHT, 2022, 7 (03)
  • [35] Composite score of PD-1+CD8+ tumor-infiltrating lymphocytes and CD57+CD8+ tumor ascites lymphocytes is associated with prognosis and tumor immune microenvironment of patients with advanced high-grade serous ovarian cancer
    He, Tianhui
    Zhang, Jie
    Zeng, Lin
    Yin, Zhongnan
    Yu, Bo
    Zhang, Xi
    Yang, Xiaoxue
    Shang, Chunliang
    Xue, Lixiang
    Guo, Hongyan
    CHINESE JOURNAL OF CANCER RESEARCH, 2025, 37 (01)
  • [36] Prognostic Significance of Tumor-infiltrating CD8+ or CD3+ T Lymphocytes and Interleukin-2 Expression in Radically Resected Non-small Cell Lung Cancer
    Tian, Chuntao
    Lu, Shixin
    Fan, Qingxia
    Zhang, Weijie
    Jiao, Shunchang
    Zhao, Xiao
    Wu, Zhiyong
    Sun, Liang
    Wang, Liuxing
    CHINESE MEDICAL JOURNAL, 2015, 128 (01) : 105 - 110
  • [37] Prognostic value of CD8+ tumor-infiltrating T cells in patients with breast cancer: A systematic review and meta-analysis
    Sun, Yu-Pei
    Ke, You-Li
    Li, Xiao
    ONCOLOGY LETTERS, 2023, 25 (01)
  • [38] Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma
    van Steenwijk, P. J. de Vos
    Ramwadhdoebe, T. H.
    Goedemans, R.
    Doorduijn, E. M.
    van Ham, J. J.
    Gorter, A.
    van Hall, T.
    Kuijjer, M. L.
    van Poelgeest, M. I. E.
    van der Burg, S. H.
    Jordanova, E. S.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (12) : 2884 - 2894
  • [39] Tumor-Infiltrating CD45RO+-Cell Density, but Not CD3+, CD8+, or FOXP3+-Cell Density, Has a Prognostic Role in Colorectal Cancer, Independent of Molecular Features.
    Nosho, K.
    Dranoff, G.
    Fuchs, C.
    Ogino, S.
    MODERN PATHOLOGY, 2011, 24 : 160A - 160A
  • [40] Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation
    Ye, Zhenmin
    Tang, Chaoke
    Xu, Shulin
    Zhang, Bei
    Zhang, Xueshu
    Moyana, Terence
    Yang, Jicheng
    Xiang, Jim
    CELLULAR & MOLECULAR IMMUNOLOGY, 2007, 4 (04) : 277 - 285